OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 4, 2026
Rhea-AI Summary
OrthoPediatrics (Nasdaq: KIDS) will release its second quarter 2026 financial results on Tuesday, August 4, 2026, after the market close. The company will host a conference call the same day at 4:30 p.m. ET, with a live and archived webcast available on its website for at least 90 days.
Positive
- None.
Negative
- None.
News Market Reaction – KIDS
In the Jul 22 session, KIDS declined 1.18%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 16 | First-quarter earnings date | Neutral | +1.3% | Scheduled first-quarter results release and conference call for April 30 |
| Feb 12 | Full-year earnings date | Neutral | +1.0% | Scheduled fourth-quarter and full-year results release for February 26 |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Both prior earnings-date announcements were followed by positive 24-hour reactions of 1.33% and 1.02%.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WARSAW, Ind., July 21, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its second quarter 2026 financial results on Tuesday, August 4, 2026 after the market closes. OrthoPediatrics will host a conference call on Tuesday, August 4, 2026 at 4:30 p.m. ET to discuss the results.
Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.orthopediatrics.com, on the Investors page in the Events & Presentations section. The webcast will be available for replay for at least 90 days after the event.
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 90 systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 75 countries outside the United States. For more information, please visit www.orthopediatrics.com. For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit www.opsb.com.
Investor Contact
Philip Trip Taylor
Gilmartin Group
philip@gilmartinir.com
415-937-5406
